INTYMGO
DEAD

Serial Number

79297679

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

INTYMGO Trademark

Serial Number: 79297679 • Registration: 6324988

INTYMGO is a trademark filed by NOVARTIS AG on August 18, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,170 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 18, 2020

Registration Date

April 20, 2021

Published for Opposition

February 2, 2021

Cancellation Date

April 23, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 12, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
May 12, 2025 DETH
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 23, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jun 23, 2024 DETH
NOTIFICATION PROCESSED BY IB
Jun 13, 2021 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 21, 2021 FICS
FINAL DISPOSITION PROCESSED
May 21, 2021 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 20, 2021 GPAR
REGISTERED-PRINCIPAL REGISTER
Apr 20, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 2, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Jan 30, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 13, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 13, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 13, 2021 NONP
APPLICATION FILING RECEIPT MAILED
Jan 5, 2021 MAFR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 4, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2021 COAR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2020 CNSA
ASSIGNED TO EXAMINER
Dec 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 30, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 12, 2020 REPR